SciBase Holding AB
5J3
Company Profile
Business description
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. The company's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company operates in two segments, which include skin cancer and skin barrier assessment. The majority of the revenue is generated from skin cancer segment.
Contact
Landsvagen 39
Sundbyberg
Stockholm172 63
SWET: +46 841062000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
34
Stocks News & Analysis
stocks
Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief
We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,161.50 | 50.00 | -0.54% |
| CAC 40 | 8,330.97 | 16.23 | -0.19% |
| DAX 40 | 25,286.24 | 134.42 | -0.53% |
| Dow JONES (US) | 49,149.63 | 42.36 | -0.09% |
| FTSE 100 | 10,184.35 | 47.00 | 0.46% |
| HKSE | 26,882.22 | 117.59 | -0.44% |
| NASDAQ | 23,471.75 | 238.13 | -1.00% |
| Nikkei 225 | 53,785.25 | 555.98 | -1.02% |
| NZX 50 Index | 13,659.52 | 98.19 | -0.71% |
| S&P 500 | 6,926.60 | 37.14 | -0.53% |
| S&P/ASX 200 | 8,837.30 | 43.70 | -0.49% |
| SSE Composite Index | 4,101.52 | 24.57 | -0.60% |